Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biotechnology Instruments Market CAGR Outlook And Future Development
The biotechnology instruments market size has experienced significant growth in recent years. It is projected to increase from $80.9 billion in 2025 to $86.43 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.8%. The expansion during the past period can be attributed to factors such as restricted automation in biotechnology laboratories, dependence on manual sample processing, expanding pharmaceutical and biotech research, the adoption of conventional diagnostic instruments, and a rising demand for laboratory consumables.
The biotechnology instruments market is anticipated to experience robust expansion over the coming years. It is projected to reach $111.27 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is fueled by several factors, such as the creation of advanced lab automation tools, the incorporation of AI and robotics into research processes, the broadening scope of genomics and proteomics investigations, increased financial commitment to pharmaceutical R&D, and the implementation of cloud-based data management systems. Key developments expected within this period encompass the increased use of lab automation instruments, a surging need for high-throughput screening and analysis, the continued expansion of proteomics and genomics research, the growing application of IVD instruments in clinical diagnostics, and a heightened emphasis on quality control and adherence to regulations.
Get A Free Sample Report With In-Depth Market Insights:
Biotechnology Instruments Market Growth Backed By Core Demand Fundamentals
The expanding occurrence of chronic diseases is projected to drive the future expansion of the biotechnology instruments market. These persistent health issues, also referred to as chronic conditions or illnesses, endure for prolonged durations, commonly extending beyond three months. Factors contributing to the widespread nature of chronic diseases include detrimental lifestyle decisions, an increasingly older demographic, and improved detection and diagnostic capabilities. Biotechnology instruments contribute to an enhanced quality of life for individuals suffering from chronic diseases by refining diagnostic precision, streamlining therapeutic approaches, and facilitating more effective disease oversight. Moreover, these instruments aid in identifying prospective drug compounds and deciphering their impact on chronic ailments. For instance, the National Health Service, a UK-based government department, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition where blood sugar levels are elevated but not high enough for a diabetes diagnosis) in 2023. This figure showed an 18% rise from the 3,065,825 cases recorded in 2022. Consequently, the escalating need stemming from chronic diseases is fueling the expansion of the biotechnology instruments market.
Biotechnology Instruments Market Segment Performance And Emerging Opportunities
The biotechnology instruments market covered in this report is segmented –
1) By Product: Lab Automation Instruments, Life Science Consumables, In Vitro Diagnostic (IVD) Instruments
2) By Application: Clinical Diagnostics, Drug Discovery And Development, Proteomics And genomics, Cell Analysis, Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies, Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Other End Users
Subsegments:
1) By Lab Automation Instruments: Robotic Liquid Handlers, Automated Plate Readers, Automated Workstations, Lab Sample Storage Systems
2) By Life Science Consumables: Reagents And Chemicals, Sample Collection And Transport Devices, Laboratory Plasticware, Culture Media And Kits
3) By In Vitro Diagnostic (IVD) Instruments: Molecular Diagnostic Instruments, Clinical Chemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers
Biotechnology Instruments Market Growth Trends Reshaping The Competitive Landscape
Leading companies within the biotechnology instruments market are prioritizing the creation of novel products, such as single-cell multi-omics offerings, to advance personalized medicine approaches and further genomics, proteomics, and metabolomics research. Single-cell multi-omics products are sophisticated technologies designed to analyze various types of biological data from individual cells, integrating information across multiple omics layers like genomics, transcriptomics, proteomics, and metabolomics. As an illustration, in June 2023, Singleron Biotechnologies, a Germany-based biotechnology company, introduced two innovative instruments, the NEO and the Python Junior, intended to improve the standardization of single-cell analysis workflows. The Neo system is capable of processing up to half a million cells in one run across four independent channels, thereby enabling high throughput and flexibility for handling diverse applications simultaneously. Meanwhile, the Python Junior instrument is dedicated to dissociating solid tissues into high-quality single-cell suspensions, employing a blend of mechanical treatment and enzymatic digestion to enhance the efficiency of the dissociation process.
Biotechnology Instruments Market Leading Companies And Competitive Benchmarking
Major companies operating in the biotechnology instruments market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Quest Diagnostics Inc., Avantor Inc., Agilent Technologies, Illumina Inc., Sartorius AG, Mettler Toledo, Perkin Elmer Inc., Shimadzu Corporation, Bruker Corporation, Zeiss Group, QIAGEN N.V., Novanta Inc., Cynosure LLC, Bio-Rad Laboratories Inc, Ori Biotech Limited, Hudson Robotics
View The Full Biotechnology Instruments Market Report:
Biotechnology Instruments Market Largest Region By Revenue And Market Share
North America was the largest region in the biotechnology instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
